Cargando…

Recent Advances on Drug-Loaded Mesenchymal Stem Cells With Anti-neoplastic Agents for Targeted Treatment of Cancer

Mesenchymal stem cells (MSCs), as an undifferentiated group of adult multipotent cells, have remarkable antitumor features that bring them up as a novel choice to treat cancers. MSCs are capable of altering the behavior of cells in the tumor microenvironment, inducing an anti-inflammatory effect in...

Descripción completa

Detalles Bibliográficos
Autores principales: Babajani, Amirhesam, Soltani, Pegah, Jamshidi, Elham, Farjoo, Mohammad Hadi, Niknejad, Hassan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7390947/
https://www.ncbi.nlm.nih.gov/pubmed/32793565
http://dx.doi.org/10.3389/fbioe.2020.00748
_version_ 1783564548436918272
author Babajani, Amirhesam
Soltani, Pegah
Jamshidi, Elham
Farjoo, Mohammad Hadi
Niknejad, Hassan
author_facet Babajani, Amirhesam
Soltani, Pegah
Jamshidi, Elham
Farjoo, Mohammad Hadi
Niknejad, Hassan
author_sort Babajani, Amirhesam
collection PubMed
description Mesenchymal stem cells (MSCs), as an undifferentiated group of adult multipotent cells, have remarkable antitumor features that bring them up as a novel choice to treat cancers. MSCs are capable of altering the behavior of cells in the tumor microenvironment, inducing an anti-inflammatory effect in tumor cells, inhibiting tumor angiogenesis, and preventing metastasis. Besides, MSCs can induce apoptosis and inhibit the proliferation of tumor cells. The ability of MSCs to be loaded with chemotherapeutic drugs and release them in the site of primary and metastatic neoplasms makes them a preferable choice as targeted drug delivery procedure. Targeted drug delivery minimizes unexpected side effects of chemotherapeutic drugs and improves clinical outcomes. This review focuses on recent advances on innate antineoplastic features of MSCs and the effect of chemotherapeutic drugs on viability, proliferation, and the regenerative capacity of various kinds of MSCs. It also discusses the efficacy and mechanisms of drug loading and releasing procedures along with in vivo and in vitro preclinical outcomes of antineoplastic effects of primed MSCs for clinical prospection.
format Online
Article
Text
id pubmed-7390947
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-73909472020-08-12 Recent Advances on Drug-Loaded Mesenchymal Stem Cells With Anti-neoplastic Agents for Targeted Treatment of Cancer Babajani, Amirhesam Soltani, Pegah Jamshidi, Elham Farjoo, Mohammad Hadi Niknejad, Hassan Front Bioeng Biotechnol Bioengineering and Biotechnology Mesenchymal stem cells (MSCs), as an undifferentiated group of adult multipotent cells, have remarkable antitumor features that bring them up as a novel choice to treat cancers. MSCs are capable of altering the behavior of cells in the tumor microenvironment, inducing an anti-inflammatory effect in tumor cells, inhibiting tumor angiogenesis, and preventing metastasis. Besides, MSCs can induce apoptosis and inhibit the proliferation of tumor cells. The ability of MSCs to be loaded with chemotherapeutic drugs and release them in the site of primary and metastatic neoplasms makes them a preferable choice as targeted drug delivery procedure. Targeted drug delivery minimizes unexpected side effects of chemotherapeutic drugs and improves clinical outcomes. This review focuses on recent advances on innate antineoplastic features of MSCs and the effect of chemotherapeutic drugs on viability, proliferation, and the regenerative capacity of various kinds of MSCs. It also discusses the efficacy and mechanisms of drug loading and releasing procedures along with in vivo and in vitro preclinical outcomes of antineoplastic effects of primed MSCs for clinical prospection. Frontiers Media S.A. 2020-07-23 /pmc/articles/PMC7390947/ /pubmed/32793565 http://dx.doi.org/10.3389/fbioe.2020.00748 Text en Copyright © 2020 Babajani, Soltani, Jamshidi, Farjoo and Niknejad. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Bioengineering and Biotechnology
Babajani, Amirhesam
Soltani, Pegah
Jamshidi, Elham
Farjoo, Mohammad Hadi
Niknejad, Hassan
Recent Advances on Drug-Loaded Mesenchymal Stem Cells With Anti-neoplastic Agents for Targeted Treatment of Cancer
title Recent Advances on Drug-Loaded Mesenchymal Stem Cells With Anti-neoplastic Agents for Targeted Treatment of Cancer
title_full Recent Advances on Drug-Loaded Mesenchymal Stem Cells With Anti-neoplastic Agents for Targeted Treatment of Cancer
title_fullStr Recent Advances on Drug-Loaded Mesenchymal Stem Cells With Anti-neoplastic Agents for Targeted Treatment of Cancer
title_full_unstemmed Recent Advances on Drug-Loaded Mesenchymal Stem Cells With Anti-neoplastic Agents for Targeted Treatment of Cancer
title_short Recent Advances on Drug-Loaded Mesenchymal Stem Cells With Anti-neoplastic Agents for Targeted Treatment of Cancer
title_sort recent advances on drug-loaded mesenchymal stem cells with anti-neoplastic agents for targeted treatment of cancer
topic Bioengineering and Biotechnology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7390947/
https://www.ncbi.nlm.nih.gov/pubmed/32793565
http://dx.doi.org/10.3389/fbioe.2020.00748
work_keys_str_mv AT babajaniamirhesam recentadvancesondrugloadedmesenchymalstemcellswithantineoplasticagentsfortargetedtreatmentofcancer
AT soltanipegah recentadvancesondrugloadedmesenchymalstemcellswithantineoplasticagentsfortargetedtreatmentofcancer
AT jamshidielham recentadvancesondrugloadedmesenchymalstemcellswithantineoplasticagentsfortargetedtreatmentofcancer
AT farjoomohammadhadi recentadvancesondrugloadedmesenchymalstemcellswithantineoplasticagentsfortargetedtreatmentofcancer
AT niknejadhassan recentadvancesondrugloadedmesenchymalstemcellswithantineoplasticagentsfortargetedtreatmentofcancer